Sign in
Explore the registryTrack Dapagliflozin's trials

Effects Dapagliflozin on Inflammatory Markers Erythropoiesis and Iron Metabolism in Patients With Type 2 Diabetes and CKD

Dapagliflozin (DAPA)OngoingNot yet recruitingPhase 3Open NCT06820567 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…